Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre
- 1 November 2001
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 34 (2) , 243-252
- https://doi.org/10.1016/s0169-5002(01)00247-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Breast cancer: delays, dilemmas, and delusionsThe Lancet, 1999
- Variation in survival of patients with lung cancer in Europe, 1985–1989European Journal Of Cancer, 1998
- The impact of delayed diagnosis of lung cancer on the stage at the time of operationEuropean Journal of Cardio-Thoracic Surgery, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancerEuropean Journal Of Cancer, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival modelEuropean Journal Of Cancer, 1993
- The use of discriminant analysis to guide palliative treatment for lung cancer patientsClinical Oncology, 1992
- ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSESThe Lancet, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958